Field Medical Unveils First Human Data on Focal PFA for Scar VT at Heart Rhythm 2025
Field Medical Presents Groundbreaking Human Data on Focal PFA at Heart Rhythm 2025
Field Medical Inc, a forerunner in pulsed field ablation (PFA) technology, has made spectacular announcements at the Heart Rhythm 2025 conference in San Diego. Their standout presentation showcased the FieldForce™ Ablation System, revealing the first human data related to the use of focal PFA for managing scar-related ventricular tachycardia (VT), a condition notorious for its complexity and high recurrence rates.
Unveiling Innovations
The unveiling marks a pivotal moment in arrhythmia treatment, particularly for scar VT, which poses a significant challenge for even the most adept electrophysiologists due to its fibrotic substrate. This innovative PFA technology aims to redefine treatment possibilities, bringing enhanced solutions to a field long dominated by complex challenges.
During the conference, which is expected to draw over 9,000 attendees and 2,000 expert faculty, Field Medical is presenting eight scientific presentations, including live case demonstrations, poster sessions, and a prominent satellite symposium. Critical findings will culminate in the VCAS trial results on April 27, where acute results from the first human assessments of focal PFA for scar-related VT will be disclosed.
Expert Insights
Dr. Steven Mickelsen, CEO and founder of Field Medical, highlighted the potential of the FieldForce™ Ablation System, stating, “For decades, ventricular tachycardia has presented a challenge even for the most skilled electrophysiologists due to the complexity of scar substrates. With FieldForce, we are not just iterating; we are redefining what is possible.” This statement underscores the commitment to advancing technology while meeting the pressing needs within electro physiology.
The FieldForce system is poised to enhance treatment precision and patient outcomes, addressing a significant unmet need in the realm of cardiac ablation. As part of their ongoing mission, Field Medical continues to display its dedication to furthering scientific innovations, ultimately shaping the future of scar VT and managing peripheral atrial fibrillation.
The Significance of Heart Rhythm 2025
Heart Rhythm 2025 is recognized as the premier global meeting focused on cardiac rhythm science. It gathers a plethora of researchers and practitioners, fostering an environment for collaboration and knowledge-sharing regarding the latest advancements in electrophysiology. Field Medical’s substantial participation emphasizes their role in leading this dialogue.
Diverse Presentations and Events at Heart Rhythm
Field Medical's schedule at the conference exemplifies their commitment to educational outreach and clinical excellence. The live case demonstrations, such as SLT with Focal Force-Sensing PFA and PVI with FieldForce™, will showcase real-time applications of their cutting-edge technology, facilitated by notable electrophysiologists including Dr. Vivek Reddy and Dr. Petr Neužil.
Posters detailing studies such as “Treatment of Refractory VT with Investigational PFA System” and “Transmural Lesions with Focal PFA” are designed to propagate knowledge and promote further research into these vital areas of cardiac health.
Additionally, the satellite symposium, “PFA in the Ventricle: The Future of Ablation,” promises to be a critical gathering for thought leaders in the field, providing insights into future directions in electrophysiological treatments.
Field Medical: A Brief Background
Founded in 2022, Field Medical has rapidly emerged as a pioneer in innovative pulsed electric field ablation technologies. The company focuses on meeting the complex needs of modern cardiac ablation, led by Dr. Mickelsen, whose groundbreaking platform laid the foundation for contemporary PFA advancements. Their work has garnered esteemed recognition, including FDA designation as an innovative device.
As the conference progresses, the anticipation surrounding these presentations illustrates the pivotal changes on the horizon for cardiac care. The unveiling of these technologies at Heart Rhythm 2025 signifies a hopeful future for patients grappling with challenging arrhythmias.
For more information on Field Medical and project updates, visit their official website at www.fieldmedicalinc.com and follow them on LinkedIn and X.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.